This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ehrich, M. Articles by van den Boom, D. Search for Related Content PubMed PubMed Citation Articles by Ehrich, M. Articles by van den Boom, D.

Cytosine Methylation Profiles as a Molecular Marker in Non–Small Cell Lung Cancer

¹ SEQUENOM, Inc., San Diego, California and ² The University of Liverpool Cancer Research Centre, Roy Castle Lung Cancer Research Program, Liverpool, United Kingdom

Requests for reprints: Mathias Ehrich, Molecular Biology, SEQUENOM, Inc., 3595 John Hopkins Court, San Diego, CA 92121. Phone: 858-202-9068; Fax: 858-202-9084; E-mail: mehrich{at}sequenom.com.

Aberrant promoter methylation is frequently observed in different types of lung cancer. Epigenetic modifications are believed to occur before the clinical onset of the disease and hence hold a great promise as early detection markers. Extensive analysis of DNA methylation has been impeded by methods that are either too labor intensive to allow large-scale studies or not sufficiently quantitative to measure subtle changes in the degree of methylation. We used a novel quantitative DNA methylation analysis technology to complete a large-scale cytosine methylation profiling study involving 47 gene promoter regions in 96 lung cancer patients. Each individual contributed a lung cancer specimen and corresponding adjacent normal tissue. The study identified six genes with statistically significant differences in methylation between normal and tumor tissue (P < 10^–6). We explored the quantitative methylation data using an unsupervised hierarchical clustering algorithm. The data analysis revealed that methylation patterns differentiate normal from tumor tissue. For validation of our approach, we divided the samples to train a classifier and test its performance. We were able to distinguish normal from lung cancer tissue with >95% sensitivity and specificity. These results show that quantitative cytosine methylation profiling can be used to identify molecular classification markers in lung cancer. (Cancer Res 2006; 66(22): 10911-8)

This article has been cited by other articles:

				M. Ehrich, J. Turner, P. Gibbs, L. Lipton, M. Giovanneti, C. Cantor, and D. van den Boom Cytosine methylation profiling of cancer cell lines PNAS, March 25, 2008; 105(12): 4844 - 4849. [Abstract] [Full Text] [PDF]

				D. Zilberman and S. Henikoff Genome-wide analysis of DNA methylation patterns Development, November 15, 2007; 134(22): 3959 - 3965. [Abstract] [Full Text] [PDF]